Clinical Trial: A Study of LAD191 in Adults With Hidradenitis Suppurativa

U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151937) titled 'A Study of LAD191 in Adults With Hidradenitis Suppurativa' on Sept. 02.

Brief Summary: The main purpose of this study is to assess the efficacy of multiple dosing regimens of LAD191 compared to placebo in participants with moderate-to-severe Hidradenitis Suppurativa (HS) and to access the safety, tolerability, pharmacokinetic and immunogenicity in participants with moderate-to-severe HS.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Hidradenitis Suppurativa

Intervention: DRUG: LAD191

LAD191 subcutaneous injection.

OTHER: Placebo

LAD191 Placebo subcutaneous injection.

DRUG: Adalimumab

Adalimumab subcu...